Catalyst Wire Dossier Catalyst Wire Dossier

Sarclisa (isatuximab)

isatuximab · Sanofi
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Sarclisa (isatuximab), covering 2026-02-03 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Isatuximab With or Without Lenalidomide in Patients With High Risk Smoldering Multiple Myeloma (ISAMAR) [Phase 2]

See pricing